# Obstetric Liposomal Bupivacaine Via Surgical Transversus Abdominis Plane Block for Post Cesarean Pain Control

> **NCT04897841** · PHASE4 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 60 (actual)

## Conditions studied

- Cesarean Section Complications
- Pain
- Opioid Use

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine Hydrochloride
- **OTHER:** saline

## Key facts

- **NCT ID:** NCT04897841
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-11
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-10-13
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897841, "Obstetric Liposomal Bupivacaine Via Surgical Transversus Abdominis Plane Block for Post Cesarean Pain Control". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04897841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*